Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 167

The DOI matches its Crossref record.

Evaluation of alginate purification methods: Effect on polyphenol, endotoxin, and protein contamination

Dusseault, Julie, Tam, Susan K., Ménard, Martin, Polizu, Stefania, Jourdan, Guillaume, Yahia, L'Hocine, Hallé, Jean‐Pierre·2006·Journal of Biomedical Materials Research Part A

Abstract

Alginate, a polysaccharide extracted from brown seaweed, is widely used for the microencapsulation of islets of Langerhans, allowing their transplantation without immunosuppression. This natural polymer is known to be largely contaminated. The implantation of islets encapsulated using unpurified alginate leads to the development of fibrotic cell overgrowth around the microcapsules and normalization of the blood glucose is restricted to a very short period if it is achieved at all. Several research groups have developed their own purification method and obtained relatively good results. No comparative evaluation of the efficiencies of these methods has been published. We conducted an evaluative study of five different alginate preparations: a pharmaceutical‐grade alginate in its raw state, the same alginate after purification according to three different published methods, and a commercially available purified alginate. The results showed that all purification methods reduced the amounts of known contaminants, that is, polyphenols, endotoxins, and proteins, although with varying efficiencies. Increased viscosity of alginate solutions was observed after purification of the alginates. Despite a general efficiency in decreasing contamination levels, all of the purified alginates contained relatively high residual amounts of protein contaminants. Because proteins may be immunogenic, these residual proteins may have a role in persisting microcapsule immunogenicity. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res, 2006

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jbm.a.30541

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 43

  1. 10.1126/science.6776628 · DOI · Paper page
  2. 10.1016/j.tibtech.2003.11.004 · DOI · Paper page
  3. Lum ZP, 1991, Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets, Diabetes, 40, 1511, 10.2337/diab.40.11.1511 · DOI
  4. Soon‐Shiong P, 1991, An immunologic basis for the fibrotic reaction to implanted microcapsules, Transplant Proc, 23, 758
  5. 10.1097/00007890-199206000-00002 · DOI
  6. Darquy S, 1990, Comparative study of microencapsulated rat islets implanted in different diabetic models in mice, Horm Metab Res, 25, 209
  7. 10.1097/00007890-199002000-00034 · DOI
  8. Weber C, 1994, NOD mouse peritoneal cellular response to poly‐L‐lysine‐alginate microencapsulated rat islets, Transplant Proc, 26, 1116
  9. 10.1097/00007890-199104000-00002 · doi:10.1097/00007890-199104000-00002
  10. 10.1007/BF00400270 · doi:10.1007/bf00400270
  11. 10.1097/00007890-199610150-00004 · DOI
  12. 10.1097/00007890-199610150-00003 · DOI
  13. Horcher A, 1994, Transplantation of microencapsulated islets in rats: evidence for induction of fibrotic overgrowth by islet alloantigens released from microcapsules, Transplant Proc, 26, 784
  14. 10.1177/096368979700600405 · DOI
  15. 10.1097/00007890-200007270-00025 · doi:10.1097/00007890-200007270-00025
  16. 10.1163/156856293X00294 · DOI
  17. 10.1016/j.biomaterials.2004.05.013 · DOI
  18. 10.1007/s10856-005-0523-2 · DOI · Paper page
  19. 10.1038/nm0103-104 · DOI · Paper page
  20. 10.1097/01.TP.0000053749.36365.7E · DOI
  21. 10.2337/diab.38.1.S224 · DOI
  22. 10.1007/BF00400922 · DOI
  23. 10.1007/s001250050673 · DOI · Paper page
  24. 10.1111/j.1749-6632.2001.tb03833.x · DOI
  25. 10.1111/j.1749-6632.1997.tb52197.x · doi:10.1111/j.1749-6632.1997.tb52197.x
  26. 10.1007/BF00173321 · DOI · Paper page
  27. 10.1016/S0142-9612(03)00299-0 · doi:10.1016/s0142-9612(03)00299-0
  28. 10.1007/s002530050012 · DOI
  29. 10.1177/096368979400300503 · doi:10.1177/096368979400300503
  30. 10.1080/02652040010018137 · DOI
  31. 10.1111/j.1749-6632.2001.tb03832.x · doi:10.1111/j.1749-6632.2001.tb03832.x
  32. 10.1002/bit.260330112 · DOI
  33. Pedersen SS, 1989, Purification, characterization, and immunological cross‐reactivity of alginates produced by mucoid Pseudomonas aeruginosa from patients with cystic fibrosis, J Clin Microbiol, 27, 691, 10.1128/jcm.27.4.691-699.1989 · DOI
  34. 10.1002/elps.1150130156 · DOI · Paper page
  35. Miller A, 1996, Antioxidant flavonoids: structure, function and clinical usage, Altern Med Rev, 1, 103
  36. 10.1016/S1367-5931(02)00375-7 · DOI · Paper page
  37. 10.1515/BOT.1999.051 · DOI
  38. W.H.O., 1994, Environmental health criteria 161‐phenols
  39. 10.1016/S0045-6535(02)00403-4 · DOI · Paper page
  40. Surialink, 2001, Overview of sea vegetable chemical composition, Bulletin, 1
  41. Godek ML, 2004, Morphology and growth of murine cell lines on model biomaterials, Biomed Sci Instrum, 40, 7
  42. 10.1002/(SICI)1097-4636(19990915)46:4<582::AID-JBM17>3.0.CO;2-5 · doi:10.1002/(sici)1097-4636(19990915)46:4<582::aid-jbm17>3.0.co;2-5
  43. 10.1080/0265204031000140796 · doi:10.1080/0265204031000140796

Cited by

See all 167

Metadata

Authors
Dusseault, J., Tam, S. K., Ménard, M., Polizu, S., Jourdan, G., Yahia, L., & Hallé, J.
Venue
Journal of Biomedical Materials Research Part A
Publisher
Wiley
Published
2005-11
Volume
76A
Issue
2
Pages
243-251
ISSN
  • 1549-3296 (ISSN-L)
  • 1552-4965
OpenAlex
W2028091454
Cited by
167
References
0
FWCI
5.36
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluation of alginate purification methods: Effect on polyphenol, endotoxin, and protein contamination. https://app.cochat.ai/papers/10.1002/jbm.a.30541
The paper
Dusseault, J., Tam, S. K., Ménard, M., Polizu, S., Jourdan, G., Yahia, L., & Hallé, J. (2006). Evaluation of alginate purification methods: Effect on polyphenol, endotoxin, and protein contamination. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbm.a.30541

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.